Osteoarthritis, inflammation and obesity

Current Opinion in Rheumatology

Volumn 25, Issue 1, 2013, Pages 114-118

  Berenbaum, Francis ^a,b   Eymard, Florent ^a   Houard, Xavier ^a  

^a SORBONNE UNIVERSITÉ   (France)

^b HÔPITAL SAINT ANTOINE   (France)

Author keywords

Adipokines; inflammation; metabolic syndrome; obesity; osteoarthritis

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; BIOLOGICAL MARKER; CHEMERIN; COLLAGENASE 3; CXCL9 CHEMOKINE; CYCLOOXYGENASE 2; FIBROBLAST GROWTH FACTOR 2; GELATINASE B; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; INTERSTITIAL COLLAGENASE; LEPTIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; NITRIC OXIDE; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PROSTAGLANDIN E2; RESISTIN; STROMELYSIN; TOLL LIKE RECEPTOR 4;

ADIPOSE TISSUE; CLINICAL FEATURE; CYTOKINE RELEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; HAND OSTEOARTHRITIS; INFLAMMATION; KNEE OSTEOARTHRITIS; MECHANICAL STRESS; METABOLIC SYNDROME X; NONHUMAN; OBESITY; OSTEOARTHRITIS; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

ADIPOKINES; ANIMALS; ARTHRITIS, EXPERIMENTAL; BIOLOGICAL MARKERS; HUMANS; INFLAMMATION; MICE; OBESITY; OSTEOARTHRITIS; OSTEOARTHRITIS, KNEE; RABBITS;

EID: 84871252069     PISSN: 10408711     EISSN: 15316963     Source Type: Journal    
DOI: 10.1097/BOR.0b013e32835a9414     Document Type: Review

References (48)

1. Blagojevic M, Jinks C, Jeffery A, Jordan KP. Risk factors for onset of osteoarthritis of the knee in older adults: a systematic review and meta-analysis. Osteoarthritis Cartilage 2010; 18:24-33.
2. Goldring MB, Otero M. Inflammation in osteoarthritis. Curr Opin Rheumatol 2011; 23:471-478.
3. Kapoor M, Martel-Pelletier J, Lajeunesse D, et al. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol 2011; 7:33-42.
4. Yusuf E, Nelissen RG, Ioan-Facsinay A, et al. Association between weight or body mass index and hand osteoarthritis: a systematic review. Ann Rheum Dis 2010; 69:761-765.
5. Aspden RM. Obesity punches above its weight in osteoarthritis. Nat Rev Rheumatol 2011; 7:65-68.
6. Pottie P, Presle N, Terlain B, et al. Obesity and osteoarthritis: more complex than predicted! Ann Rheum Dis 2006; 65:1403-1405.
7. Gomez R, Conde J, Scotece M, et al. What's new in our understanding of the role ofadipokines in rheumatic diseases? Nat Rev Rheumatol 2011; 7:528-536.
8. Sowers M, Karvonen-Gutierrez CA, Palmieri-Smith R, et al. Knee osteoarthritis in obese women with cardiometabolic clustering. Arthritis Rheum 2009; 61:1328-1336.
9. Bijlsma JW, Berenbaum F, Lafeber FP. Osteoarthritis: an update with relevance for clinical practice. Lancet 2011;377:2115-2126.
10. Guilak F. Biomechanical factors in osteoarthritis. Best Pract Res Clin Rheu-matol 2011; 25:815-823.
11. Chauffier K, Laiguillon MC, Bougault C, et al. Induction of the chemokine IL-8/Kc by the articular cartilage: possible influence on osteoarthritis. Joint Bone Spine 2012 (in press).
12. Takao M, Okinaga T, Ariyoshi W, et al. Role of heme oxygenase-1 in inflammatory response induced by mechanical stretch in synovial cells. Inflamm Res 2011; 60:861-867.
13. Wang Y, Tang Z, Xue R, et al. Combined effects of TNF-alpha, IL-1beta, and HIF-1alpha on MMP-2 production in ACL fibroblasts under mechanical stretch: an in vitro study. J Orthop Res 2011; 29:1008-1014.
14. Sanchez C, Deberg MA, Bellahcene A, et al. Phenotypic characterization of osteoblasts from the sclerotic zones of osteoarthritic subchondral bone. Arthritis Rheum 2008; 58:442-455.
15. Sanchez C, Pesesse L, Gabay O, et al. Regulation of subchondral bone osteoblast metabolism by cyclic compression. Arthritis Rheum 2012; 64:1193-1203.
16. Brunner AM, Henn CM, Drewniak EI, et al. High dietary fat and the development of osteoarthritis in a rabbit model. Osteoarthritis Cartilage 2012; 20:584-592.
17. Louer CR, Furman BD, Huebner JL, et al. Diet-induced obesity significantly increasestheseverity of posttraumaticarthritis in mice. Arthritis Rheum 2012; 64:3220-3230.
18. Mooney RA, Sampson ER, Lerea J, et al. High-fatdietacceleratesprogression of osteoarthritis after meniscal/ligamentous injury. Arthritis Res Ther 2011; 13:R198.
19. Gierman LM, van der Ham F, Koudijs A, et al. Metabolic stress-induced inflammation plays a major role in the development of osteoarthritis in mice. Arthritis Rheum 2012; 64:1172-1181.
20. Griffin TM, Huebner JL, Kraus VB, et al. Induction of osteoarthritis and metabolic inflammation by a very high-fat diet in mice: effects of short-term exercise. Arthritis Rheum 2012; 64:443-453.
21. Osborn O, Olefsky JM. Thecellularand signaling networks linking the immune system and metabolism in disease. Nat Med 2012; 18:363-374.
22. Conde J, Scotece M, Gomez R, et al. Adipokines and osteoarthritis: novel molecules involved in the pathogenesis and progression of disease. Arthritis 2011; 2011:203901.
23. Gabay O, Berenbaum F. Adipokines in arthritis: new kids on the block. Curr Rheumatol Rev 2009; 5:226-232.
24. Massengale M, Reichmann WM, Losina E, et al. The relationship between hand osteoarthritis and serum leptin concentration in participants ofthe Third National Health and Nutrition Examination Survey. Arthritis Res Ther 2012; 14:R132.
25. Ernst MC, Sinal CJ. Chemerin: atthe crossroads of inflammation and obesity. Trends Endocrinol Metab 2010; 21:660-667.
26. Iannone F, Lapadula G. Chemerin/Chem R23 pathway: a system beyond chemokines. Arthritis Res Ther 2011; 13:104.
27. Huang K, Du G, Li L, et al. Association of chemerin levels in synovial fluid with the severity of knee osteoarthritis. Biomarkers 2012; 17:16-20.
28. Berg V, Sveinbjornsson B, Bendiksen S, et al. Human articularchondrocytes express Chem R23 and chemerin; Chem R23 promotes inflammatory signalling upon binding the ligand chemerin(21-157). Arthritis Res Ther 2010; 12:R228.
29. Eisinger K, Bauer S, Schaffler A, et al. Chemerin induces CCL2 and TLR4 in synovial fibroblasts of patients with rheumatoid arthritis and osteoarthritis. Exp Mol Pathol 2012; 92:90-96.
30. Dumond H, Presle N, Terlain B, et al. Evidence for a key role of leptin in osteoarthritis. Arthritis Rheum 2003; 48:3118-3129.
31. Hui W, Litherland GJ, Elias MS, et al. Leptin produced byjointwhite adipose tissue induces cartilage degradation via upregulation and activation of matrix metalloproteinases. Ann Rheum Dis 2012; 71:455-462.
32. Gosset M, Berenbaum F, Salvat C, et al. Crucial role of visfatin/pre-B cell colony-enhancing factor in matrixdegradation and prostaglandin E2 synthesis in chondrocytes: possible influence on osteoarthritis. Arthritis Rheum 2008; 58:1399-1409.
33. Jacques C, Holzenberger M, Mladenovic Z, et al. Proinflammatory actions of visfatin/nicotinamide phosphoribosyltransferase (Nampt) involve regulation of insulin signaling pathway and Nampt enzymatic activity. J Biol Chem 2012; 287:15100-15108.
34. Yammani RR, Loeser RF. Extracellular nicotinamide phosphoribosyltransfer- ase (NAMPT/visfatin) inhibits insulin-like growth factor-1 signaling and pro-teoglycan synthesis in human articularchondrocytes. Arthritis Res Ther2012; 14:R23.
35. Mc Nulty AL, Miller MR, O'Connor SK, Guilak F. The effects of adipokines on cartilage and meniscus catabolism. Connect Tissue Res 2011; 52:523-533.
36. Francin PJ, Guillaume C, Humbert AC, et al. Association between the chondrocyte phenotype and the expression of adipokines and their receptors: evidence for a role of leptin but not adiponectin in the expression of cartilage-specific markers. J Cell Physiol 2011; 226:2790-2797.
37. Patra D, Sandell LJ. Recent advances in biomarkers in osteoarthritis. Curr Opin Rheumatol 2011; 23:465-470.
38. Yusuf E, Ioan-Facsinay A, Bijsterbosch J, et al. Association between leptin, adiponectin and resistin and long-term progression of hand osteoarthritis. Ann Rheum Dis 2011; 70:1282-1284.
39. Choe JY, Bae J, Jung HY, et al. Serum resistin level is associated with radiographic changes in hand osteoarthritis: cross-sectional study. Joint Bone Spine 2012; 79:160-165.
40. Berry PA, Jones SW, Cicuttini FM, et al. Temporal relationship between serum adipokines, biomarkers of bone and cartilage turnover, and cartilage volume loss in a population with clinical knee osteoarthritis. Arthritis Rheum 2011; 63:700-707.
41. Koskinen A, Juslin S, Nieminen R, et al. Adiponectin associates with markers of cartilage degradation in osteoarthritis and induces production of pro-inflammatory and catabolic factors through mitogen-activated protein kinase pathways. Arthritis Res Ther 2011; 13:R184.
42. De Boer TN, van Spil WE, Huisman AM, et al. Serum adipokines in osteo-arthritis; comparison with controls and relationship with local parameters of synovial inflammation and cartilage damage. Osteoarthritis Cartilage 2012; 20:846-853.
43. Clockaerts S, Bastiaansen-Jenniskens YM, Runhaar J, et al. The infrapatellar fatpad should beconsidered asanactiveosteoarthriticjointtissue: anarrative review. Osteoarthritis Cartilage 2010; 18:876-882.
44. Klein-Wieringa IR, Kloppenburg M, Bastiaansen-Jenniskens YM, et al. The infrapatellar fat pad of patients with osteoarthritis has an inflammatory phenotype. Ann Rheum Dis 2011; 70:851-857.
45. Gandhi R, Takahashi M, Virtanen C, et al. Microarray analysis of the infra-patellar fat pad in knee osteoarthritis: relationship with joint inflammation. J Rheumatol 2011; 38:1966-1972.
46. Clockaerts S, Bastiaansen-Jenniskens YM, Feijt C, et al. Cytokine production by infrapatellarfat pad can be stimulated by interleukin 1betaand inhibited by peroxisome proliferator activated receptor alpha agonist. Ann Rheum Dis 2012; 71:1012-1018.
47. Bastiaansen-Jenniskens YM, Clockaerts S, Feijt C, et al. Infrapatellarfatpad of patientswith end-stage osteoarthritis inhibits catabolic mediators in cartilage. Ann Rheum Dis 2011; 71:288-294.
48. Richette P, Poitou C, Garnero P, et al. Benefits of massive weight loss on symptoms, systemic inflammation and cartilage turnover in obese patients with knee osteoarthritis. Ann Rheum Dis 2011; 70:139-144.